OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Allergy Asthma & Immunology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Anaphylaxis to a particular brew of beer due to specific strains of Saccharomyces cerevisiae	281
Table of Contents	114
Stepping up our game with secondary immune deficiency	90
Information for Readers	89
Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing?	85
A new frontier in anaphylaxis management?	70
Table of Contents	67
Tastes great, less filling! Randomized trial comparing perceived palatability of dexamethasone preparations in children	65
Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product	62
Immune-related cutaneous adverse events	58
Kounis syndrome	57
Eosinophilic granulomatosis with polyangiitis presenting as aspirin–exacerbated respiratory disease	54
Integrated phase I pharmacokinetics and pharmacodynamics of epinephrine administered through sublingual film, autoinjector, or manual injection	50
Metabolomic profiles in allergic rhinitis	49
Use of omalizumab for management of idiopathic anaphylaxis	46
Challenge-confirmed diagnosis restores quality of life in cofactor-dependent wheat allergy	43
Psychometric Validation of the STARR-15 in the United States	42
Functional testing of humoral immunity in the Prevnar 20 era	40
Outcomes and variation in management of penicillin allergy in pregnant patients presenting for prenatal care	40
The Antibuddies	39
A second look at secondary hypogammaglobulinemia	39
UTILIZING DUPILUMAB IN TREATMENT OF ATOPIC DERMATITIS IN A PEDIATRIC PATIENT WITH HYPER-IGE SYNDROME	38
Understanding advances in inborn errors of immunity for the practicing allergist-immunologist	38
Information for Readers	38
Quality of life in patients with hereditary angioedema in Canada	37

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis	36
Seafood-induced anaphylaxis in children presenting to Canadian emergency departments	36
Editorial Board	36
Cross-sectional study of urinary biomarkers of environmental tobacco and e-cigarette exposure and asthma morbidity	35
Editorial Board	35
From the pages of AllergyWatch	34
Itching and Burning Man	34
Establishment of fluorescence multi-flow cytometric immunoassay for the simultaneous quantitative detection of six allergen-sIgE antibodies	33
Hereditary angioedema with normal C1-inhibitor	33